Clinical Trials Directory

Trials / Completed

CompletedNCT02836379

Quality of Life Study Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative Intent

Quality of Life Study in Patients With Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative Intent

Status
Completed
Phase
Study type
Observational
Enrollment
79 (actual)
Sponsor
Angelini Farmacéutica · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In the context of radiotherapy, control of breakthrough pain represents a special challenge. Patients undergoing radiotherapy may experience different situations of pain that may be due to the need to remain immobilized during radiotherapy session, the need to wear an immobilization mask (head and neck cancer), the odynophagia caused by mucositis, defecation after the development of proctitis, or sudden pain during the night causing sleep disturbances. In a survey conducted in radiation oncology services more than half of patients treated with radiotherapy experienced pain, and 39% of patients reported that their pain was not treated properly. This situation may increase the patient's anxiety, dissatisfaction with treatment, affect their quality of life and can even come to refuse radiotherapy treatment. This post-authorization observational study will assess the quality of life of cancer patients with breakthrough cancer pain treated in radiotherapy services in Spanish hospitals.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention

Timeline

Start date
2016-07-08
Primary completion
2017-11-01
Completion
2018-02-28
First posted
2016-07-19
Last updated
2018-03-05

Locations

11 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT02836379. Inclusion in this directory is not an endorsement.